Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant

Objective/background: Clostridium difficile infection (CDI) is a potential complication during hematopoietic stem cell transplantation (HSCT), and no specific recommendations exist regarding treatment of CDI in allogeneic SCT patients. Use of metronidazole and oral vancomycin has been associated wit...

Description complète

Détails bibliographiques

Auteurs principaux:	Laura Prohaska, Zahra Mahmoudjafari, Leyla Shune, Anurag Singh, Tara Lin, Sunil Abhyankar, Siddhartha Ganguly, Dennis Grauer, Joseph McGuirk, Lisa Clough
Format:	Artigo
Langue:	Inglês
Publié:	Wolters Kluwer Medknow Publications 2018-10-01
Collection:	Hematology/Oncology and Stem Cell Therapy
Sujets:	allogeneic stem cell transplantation clostridium difficile fidaxomicin vancomycin
Accès en ligne:	https://journals.lww.com/10.1016/j.hemonc.2018.05.001
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!